SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-11-087283
Filing Date
2011-09-28
Accepted
2011-09-28 14:21:56
Documents
2
Group Members
ARNOLD L. ORONSKYBRUCE A. CLEVELANDCHRISTOPHER B. EHRLICHDOUGLAS A. PEPPERGILBERT H. KLIMANHARVEY B. CASHINTERWEST MANAGEMENT PARTNERS IX, LLCINTERWEST PARTNERS IX, L.P.KHALED A. NASRNINA S. KJELLSONPHILIP T. GIANOSTHOMAS L. ROSCHW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D c22812sc13d.htm SC 13D 244689
2 EXHIBIT A c22812exv99wa.htm EX-99.A 13605
  Complete submission text file 0000950123-11-087283.txt   260401
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81821 | Film No.: 111111602
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

IRS No.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D